Olema Oncology
Olema Oncology is seeking a Program Manager, CMC to lead integrated CMC program planning and execution across clinical development stages. The role involves cross-functional collaboration to translate CMC strategies into actionable plans, ensure timely progress, and support regulatory submissions.
Headquarters
San Francisco, California, United States
Company Size
51-200 employees
Founded
2007
Olema Oncology is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel targeted therapies for metastatic breast cancer and beyond. The company leverages its deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance to advance its pipeline, including Phase 3 breast cancer trials and a KAT6 inhibitor program being evaluated in solid tumors and prostate cancer. Founded in 2006 and headquartered in San Francisco, California, Olema trades on Nasdaq under the ticker OLMA.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Olema Oncology.
135% above the average for this role
Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference
3 weeks ago
Senior Manager CMC Dossier Strategy and Leadership
AbbVie
Senior Director CMC Regulatory Affairs
Immunovant, Inc.
Associate Director, CMC Regulatory Affairs (Hematology/Oncology)
Regeneron Pharmaceuticals
Senior Director, CMC Lead Product Development
Cytokinetics
Senior Manager, Regulatory Affairs CMC (Oncology)
Sumitomo Pharma America, Inc
CMC Program Lead
Telix Pharmaceuticals